InterCure Ltd. Form 6-K Summary
Business context and reporting period
InterCure Ltd., an Israeli foreign private issuer, filed this Form 6-K for the month of December 2021. The filing was submitted on December 3, 2021, under Commission File No. 001-40614. The filing identifies the company’s principal executive offices in Herzliya, Israel and indicates that it files annual reports on Form 20-F.
Financial metrics
The filing text provided does not include revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material changes versus the prior comparable period
The filing text does not provide information sufficient to identify material changes versus a prior comparable period.
Guidance, outlook, risks, and unusual items
The filing includes an exhibit index referencing Exhibit 99.1, a press release dated December 2, 2021, but the press release content is not included in the provided filing text. Accordingly, no guidance, outlook, management commentary, risks, contingencies, or unusual items can be summarized from the available text.
Investor verification points
- Obtain and review Exhibit 99.1, the December 2, 2021 press release.
- Verify whether the referenced press release contains financial results, operational developments, transactions, or forward-looking guidance.
- Consult the company’s applicable Form 20-F or other periodic reports for financial metrics and risk disclosures.